Prolactin and cortisol responses to acute intravenous clomipramine challenge in patients with mania, depression and healthy controls: Evidence for reduced serotonergic responsivity

Neuropsychobiology

Volumn 63, Issue 2, 2011, Pages 77-81

  Lykouras, L ^a   Markianos, M ^b   Hatzimanolis, Y ^b  

^a IASO GENERAL HOSPITAL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

Author keywords

Clomipramine challenge; Cortisol; Depression; Mania; Prolactin; Serotonin

Indexed keywords

CLOMIPRAMINE; HYDROCORTISONE; PROLACTIN; SEROTONIN UPTAKE INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; HAMILTON SCALE; HUMAN; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MAJOR DEPRESSION; MALE; MANIA; MOOD DISORDER; NEUROENDOCRINE SYSTEM; PRIORITY JOURNAL; PROLACTIN RELEASE; RADIOIMMUNOASSAY; SEROTONINERGIC SYSTEM; YOUNG MANIA RATING SCALE;

ADULT; AGED; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; BRAIN; CLOMIPRAMINE; DEPRESSIVE DISORDER; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY-ADRENAL SYSTEM; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX;

EID: 78650232449     PISSN: 0302282X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000323447     Document Type: Article

References (25)

1. Flores BH, Musselman DL, De Batista C, Garlow SS, Schatzberg AE, Nemeroff CB: Biology of mood disorders; in Schatzberg AE, Nemeroff CB (eds): Textbook of Psychopharmacology. Washington, American Psychiatric Publishing, 2004, pp 717-763.
2. Shiah I-S, Yatham LN: Serotonin in mania and in the mechanism of action of mood stabilizers: review of clinical studies. Bipolar Disord 2000; 2: 77-92.
3. Yatham LN, Steiner M: Neuroendocrine probes of serotonergic function: a critical review. Life Sci 1993; 53: 447-463.
4. Golden NR, Ruegg R, Brown TN Haggerty J Jr, Garbutt JC, Pedersen CA, Evans DL: Abnormal neuroendocrine responsivity to clomipramine in depression. Psychopharmacol Bull 1990; 26: 317-320.
5. Newman EM, Shapira B, Lerer B: Evaluation of central serotonergic function in affective and related disorders by the fenfluramine challenge test: a critical review. Int J Neuropsychopharmacol 1998; 1: 49-69.
6. Kapitany T, Schindl M, Schindler SD, Hebelmann B, Füreder T, Barnas C, et al: The citalopram challenge test in patients with major depression and in healthy controls. Psychiatry Res 1999;88: 75-88.
7. Sobzak S, Honig A, van Dulnen MA, Riedel WJ: Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. Bipolar Disord 2002; 4: 347-356.
8. Sher L, Oquendo AM, Li S, Ellis S, Brodsky SB, Malone MK, et al: Prolactin response to fenfluramine administration in patients with unipolar and bipolar depression and healthy controls. Psychoneuroendocrinology 2002; 28: 559-573.
9. Golden RN, Heine AD, Ekstrom D, Bebchuk JM, Leatherman ME, Garbatt J: A longitudinal study of serotonergic function in depression. Neuropsychopharmacology 2002; 26: 653-659.
10. van Praag HM, Lemus C, Kahn R: Hormonal probes of central serotonergic activity: do they really exist? Biol Psychiatry 1987; 22: 86-98.
11. Hyttel J: Citalopram-pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog Neuro- Psychopharmacol Biol Psychiatry 1982; 6: 277-295.
12. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 33: 55-62.
13. Young RC, Biggs YT, Ziegler VE, Meyer DA: A rating scale for mania: reliability, validity, sensitivity. Br J Psychiatry 1978; 133: 423-435.
14. Yatham LN: Buspirone induced prolactin release in mania. Biol Psychiatry 1994; 35: 553-556.
15. Yatham LN: Prolactin and cortisol responses to fenfluramine challenge in mania. Biol Psychiatry 1996; 39: 285-288.
16. Thakore HJ, O'Keane V, Dinan GT: D -fenfluramine- induced prolactin responses in mania: evidence for serotonergic subsensitivity. Am J Psychiatry 1996; 153: 1460-1463.
17. Coccaro EF, Kavoussi RJ: Neuropsychopharmacologic challenge in biological psychiatry. Clin Chem 1994; 40: 319-327.
18. Coccaro EF, Siever LJ, Klar HM, Maurer G, Cochrane K, Cooper TB, Mohs RC, Davis KL: Serotonergic studies in patients with affective and personality disorders: correlates with suicidal and impulsive-aggressive behaviour. Arch Gen Psychiatry 1989; 46: 587-599.
19. Corrêa H, Duval F, Mokrani M, Bailey P, Trémeau F, Staner L, Diep TS, Hodé Y, Crocq MA, Macher JP: Prolactin response to D -fenfluramine and suicidal behavior in depressed patients. Psychiatry Res 2000; 93: 189-199.
20. Duval F, Mokrani MC, Correa H, Bailey P, Valvebenito M, Monreal J, Crock MA, Macher JP: Lack of effect of HPA axis hyperactivity on hormonal responses to D -fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology 2001; 26: 521-537.
21. Prochazka H, Sjögren M, Agren H: Oral D - fenfluramine test in treatment-refractory depression: plasma prolactin response compared in patients with and without suicide attempts and in a healthy reference group. J Affect Disord 2000; 57: 201-208.
22. Park SB, Williamson DJ, Cowen PJ: 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to D - fenfluramine. Psychol Med 1996; 26: 1191-1196.
23. Thompson PA, Maes M, Meltzer HY: Effect of the placebo control condition in neuroendocrine challenge studies. Psychiatry Res 1994; 52: 317-326.
24. Lichtenberg P, Shapira B, Gillon D, Kindler S, Cooper TB, Newman ME, Lerer B: Hormone responses to fenfluramine and placebo challenge in endogenous depression. Psychiatry Res 1992; 43: 137-146.
25. Nurnberger JI Jr, Berettini W, Simmons- Alling S, Lawrence D, Brittain H: Blunted ACTH and cortisol response to afternoon tryptophan infusion in euthymic bipolar patients. Psychiatry Res 1990; 31: 57-67.